Collectively, the data establish that the disruption in PIMT’s activity (either expression or phosphorylation) attenuates gluconeogenesis and ameliorates hyperglycemia by improving hepatic insulin sensitivity and suppressing glucose biosynthesis from non-carbohydrate sources. The gene discussed is TGS1; the disease is Hyperglycemia.